Study of hemolytic anemia in antiphospholipid syndrome
Part of Immune system & allergy clinical trials.
This study looks at how autoimmune hemolytic anemia (when the body attacks its own red blood cells) relates to antiphospholipid syndrome (a condition that increases blood clot risk). It aims to better understand this connection, which may help improve care for people with both conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with antiphospholipid syndrome.
- You have anemia that is due to hemolysis (your body destroying red blood cells).
- Your anemia is caused by an autoimmune process, not by another condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who test positive for antiphospholipid antibodies on more than one blood test. It helps researchers better understand the condition and how to follow patients over time.
This study compares the health outcomes of patients who have antiphospholipid syndrome, a condition that increases blood clot risk. It looks at whether there are differences between primary (no other related autoimmune disease) and secondary (with another autoimmune disease like lupus) forms.
This study looks at three blood markers (MPV, PLR, and NLR) in people with antiphospholipid syndrome (APS) to see if they differ between primary APS (no other autoimmune disease) and secondary APS (with lupus or another autoimmune condition). It may help doctors better understand and manage APS.
This study looks at adults who are in the hospital with acquired hemolytic anemia, a condition where the body destroys red blood cells too quickly. The goal is to understand this condition better and improve care for patients like you.
This study looks at how platelet counts change over time in people with antiphospholipid syndrome (APS), a condition that can cause blood clots and pregnancy problems. It may help doctors better understand and manage low platelets in APS patients.
This study looks at lab results and clinic information in people who have antiphospholipid antibodies. The goal is to better understand these antibody-positive conditions and what happens over time, which may help improve care.
Hear when a new Anti Phospholipid Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.